Monday, August 19, 2019

Alcami Announces Industry-Leading Analytical Testing Turnaround Time

Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announces the advancement of the drug development process with the company's new, dramatically-reduced analytical testing turnaround...

Embrace® Active Scar Defense And Serena Williams Team Up To Talk About Motherhood, Healing...

Neodyne Biosciences, Inc. today announced they are partnering with professional tennis champion Serena Williams to raise awareness for its embrace® Active Scar Defense, an FDA cleared scar therapy system designed to prevent the formation of scar tissue...

AdvoCare International Announces the Promotion of Brett Blake as New CEO

AdvoCare International, L.P. today announced the promotion of Brett Blake to Chief Executive Officer, replacing industry-veteran Brian Connolly who served as interim-CEO during the extensive executive search. Connolly will continue to work closely with Brett serving as...

The Menarini Group Announced Marketing Authorization Application for Delafloxacin

The Menarini Group announced today that on March 6th 2017 it submitted a Marketing Authorization Application for delafloxacin at the European Medicines Agency (EMA) under the trade name Quofenix. The proposed indication for delafloxacin in Europe is the...

Thermal Imaging Market Size Poised to Reach $6.50 Billion At 9.1% CAGR By 2020...

The global Thermal Imaging Market size was valued at USD 3.2 billion in 2012 and is poised to reach USD 6.50 billion by 2020, with a CAGR of 9.1%. High demand of thermal imaging across residential and commercial sector is...

Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study

The first drug designed to eliminate autoantibodies that are a major cause of heart failure and to treat heart failure symptoms was effective and well-tolerated in a Phase 1 clinical study, according to...

Prime Therapeutics Signs CareCentered Contract™ with leading manufacturer of MS drugs

Contract measures adherence, helps link price of therapy to clinical value Given the growing use and cost of multiple sclerosis (MS) medicines, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM), and Biogen,...

Mitra Biotech Partners with Gotect Diagnostic in Israel

Mitra Biotech, a global leader in advancing the personalization of cancer treatment, today announced an agreement with Gotect Diagnostic for the exclusive right to represent Mitra in Israel. Mitra's CANscript™ platform recreates a patient's own...

Enhanced Healthcare Partners Announces Investment in SCA Pharmaceuticals

Enhanced Healthcare Partners ("EHP"), a private equity firm focused exclusively on investing in the healthcare industry, has announced its investment in SCA Pharmaceuticals ("SCA"), a sterile compounding leader specializing in preparing sterile pharmaceuticals...

Mylan Launches First AP-rated Generic Avelox® Injection

Mylan N.V. today announced the U.S. launch of Moxifloxacin Hydrochloride in 0.8% Sodium Chloride Injection, 400 mg/250 mL (1.6 mg/mL) in 250 mL single-dose flexible bags, the first AP-rated generic version of Bayer's...

Connect with us

4,474FansLike
1,007FollowersFollow
12,053FollowersFollow

Popular Posts